Our analysis suggests that in sepsis patients with albumin levels exceeding 30 g/L, further elevation of albumin levels potentially continues to ameliorate the risks of mortality and acute kidney injury, albeit with a relatively marginal benefit that did not reach statistical significance in our study (G3 vs. G4). This evidence concerns the gene ALB and acute kidney injury.